anti-Apolipoprotein B MRNA Editing Enzyme, Catalytic Polypeptide-Like 3F (APOBEC3F) Antibodies

APOBEC3F is a member of the cytidine deaminase gene family. Additionally we are shipping APOBEC3F Proteins (4) and and many more products for this protein.

list all antibodies Gene Name GeneID UniProt
APOBEC3F 200316 Q8IUX4
APOBEC3F    
APOBEC3F    
How to order from antibodies-online
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Order online
  • orders@antibodies-online.com

Top anti-APOBEC3F Antibodies at antibodies-online.com

Showing 10 out of 42 products:

Catalog No. Reactivity Host Conjugate Application Images Quantity Supplier Delivery Price Details
Human Rabbit Un-conjugated WB WB Suggested Anti-APOBEC3F Antibody Titration:  0.2-1 ug/ml  Positive Control:  Human brain 100 μL Log in to see 2 to 3 Days
$289.00
Details
Human Rabbit Un-conjugated WB WB Suggested Anti-APOBEC3F Antibody Titration:  0.2-1 ug/ml  ELISA Titer:  1:1562500  Positive Control:  Human brain 100 μL Log in to see 2 to 3 Days
$319.00
Details
Human Rabbit Un-conjugated WB WB Suggested Anti-APOBEC3F Antibody Titration:  0.2-1 ug/ml  ELISA Titer:  1:12500  Positive Control:  OVCAR-3 cell lysate APOBEC3F is supported by BioGPS gene expression data to be expressed in OVCAR3 Host:  Rabbit  Target Name:  APOBEC3F  Sample Tissue:  Human 293T Whole Cell  Antibody Dilution:  1ug/ml 100 μL Log in to see 2 to 3 Days
$319.00
Details
Human Rabbit Un-conjugated FACS, IHC (p), WB Western blot analysis of APOBEC3F Antibody (N-term) (ABIN653123) in K562 cell line lysates (35 µg/lane). APOBEC3F (arrow) was detected using the purified polyclonal antibody. Formalin-fixed and paraffin-embedded human brain tissue reacted with APOBEC3F Antibody (N-term), which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. 400 μL Log in to see 10 to 11 Days
$385.00
Details
Human Rabbit Un-conjugated EIA, FACS, IHC (p), WB APOBEC3F Antibody (N-term) flow cytometry analysis of K562 cells (bottom histogram) compared to a negative control cell (top histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis. Formalin-fixed and paraffin-embedded human brain tissue reacted with APOBEC3F Antibody (N-term), which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated. 0.4 mL Log in to see 6 to 8 Days
$390.50
Details
Human Rabbit Un-conjugated ICC, IF, IHC, IHC (p), WB 100 μL Log in to see 11 to 14 Days
$507.83
Details
Human Rabbit Un-conjugated WB 50 μg Log in to see 11 to 14 Days
$551.83
Details
Human Rabbit Un-conjugated WB 50 μg Log in to see 11 to 14 Days
$551.83
Details
Human Mouse Un-conjugated ELISA, WB Western Blot detection against Immunogen (37 KDa) . 50 μL Log in to see 11 to 12 Days
$305.71
Details
Human Rabbit Un-conjugated ELISA, WB 50 μg Log in to see 2 to 3 Days
$446.88
Details

Top referenced anti-APOBEC3F Antibodies

  1. Human Polyclonal APOBEC3F Primary Antibody for ELISA, WB - ABIN566935 : Han, Wang, Dang, Zheng: APOBEC3G and APOBEC3F require an endogenous cofactor to block HIV-1 replication. in PLoS pathogens 2008 (PubMed)
    Show all 2 Pubmed References

More Antibodies against APOBEC3F Interaction Partners

Human Apolipoprotein B MRNA Editing Enzyme, Catalytic Polypeptide-Like 3F (APOBEC3F) interaction partners

  1. APOBEC3DE binds to itself, APOBEC3F, and APOBEC3G and antagonizes APOBEC3F and, to a lesser extent, APOBEC3G restriction of hepatitis B virus replication.

  2. These results indicate that APOBEC3 proteins can be copackaged and can comutate the same genomes, and can cooperate to inhibit HIV replication.

  3. an APOBEC3F/APOBEC3G hetero-oligomer can form that has unique properties compared to each APOBEC3 alone. This hetero-oligomer has increased efficiency of virus hypermutation, raising the idea that we still may not fully realize the antiviral mechanisms of endogenous APOBEC3 enzymes. Hetero-oligomerization may be a mechanism to increase their antiviral activity in the presence of Vif.

  4. virus adaptation and computational studies to interrogate the APOBEC3F-Vif interface and build a robust structural model; taken together with mutagenesis results, propose a wobble model to explain how HIV-1 Vif has evolved to bind different APOBEC3 enzymes

  5. Findings support a role for APOBEC3G/F proteins in the generation of plasma drug-resistant minority human immunodeficiency virus type 1 variants (DRMVs). However, this role seems to be limited to a small subset of mutations and does not explain most of the DRMVs evaluated.

  6. Overexpression of APOBEC3F in tumor tissues is potentially predictive for poor recurrence-free survival from hepatitis b virus-hepatocellular carcinoma patients.

  7. Our results provide genetic epidemiological evidence that A3F(APOBEC3F ) modulates HIV-1/AIDS disease progression

  8. Six residues located within the conserved HIV-1 Vif F1-, F2-, and F3-box motifs are essential for both APOBEC3C and APOBEC3F degradation, and an additional four residues are uniquely required for APOBEC3F degradation.

  9. This study showed for the first time a high level of APOBEC3F/3G editing in HIV-2 sequences from antiretroviral-naive patients.

  10. APOBEC3D/F and APOBEC3G fundamentally work as restriction factors against HIV-1 in vivo

  11. APOBEC3G is more efficient at mutating retroviral DNA than APOBEC3F.

  12. A3G and A3F inhibit porcine endogenous retrovirus replication.

  13. The rather indiscriminate RNA binding characteristics of A3G and A3F promote functionality by enabling recruitment into a wide range of retroviral particles whose packaged RNA genomes comprise divergent sequences.

  14. The nucleocapsid domain of HIV-1 Gag and a linker sequence between the two cytidine deaminase domains are required for viral packaging of APOBEC3F.

  15. Authors found that one pair of leucines in each of APOBEC3F's C-terminal and N-terminal cytidine deaminase domains jointly determined the degree of localization of APOBEC3F into HIV-1 virion cores.

  16. This approach identified the alpha3 and alpha4 helices of human APOBEC3F as important determinants of the interaction with HIV-1 Vif.

  17. APOBEC3G/F mutational hotspots in the human immunodeficiency virus genome have roles in reducing recognition by CD8+ T cells

  18. Authors found that APOBEA3G, APOBEA3F, and APOBEA3H-hapII, but not APOBEA3D, were susceptible to HIV-2 Vif-induced degradation.

  19. we demonstrate key differences in the impact of APOBEC3F- and APOBEC3G-induced mutagenesis on HIV-1

  20. APOBEC3 deaminases upregulated by IFN-beta induce E2 hypermutation of HPV16 in cervical keratinocytes.

Rhesus Monkey Apolipoprotein B MRNA Editing Enzyme, Catalytic Polypeptide-Like 3F (APOBEC3F) interaction partners

  1. APOBEC3F/G-specific responses in HIV-1-infected rhesus macaques are CD8+ T cell mediated.

  2. Increased APOBEC3G and APOBEC3F expression is associated with low viral load and prolonged survival in simian immunodeficiency virus infected rhesus monkeys.

  3. APOBEC3 proteins restrict xenotropic murine leukemia virus-related virus infections in a Macaca mulatta model.

APOBEC3F Antigen Profile

Protein Summary

This gene is a member of the cytidine deaminase gene family. It is one of seven related genes or pseudogenes found in a cluster, thought to result from gene duplication, on chromosome 22. Members of the cluster encode proteins that are structurally and functionally related to the C to U RNA-editing cytidine deaminase APOBEC1. It is thought that the proteins may be RNA editing enzymes and have roles in growth or cell cycle control. Alternatively spliced transcript variants encoding different isoforms have been identified.

Gene names and symbols associated with APOBEC3F

  • apolipoprotein B mRNA editing enzyme catalytic subunit 3F (APOBEC3F) antibody
  • apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3F (APOBEC3F) antibody
  • A3F antibody
  • APOBEC3F antibody
  • ARP8 antibody
  • BK150C2.4.MRNA antibody
  • KA6 antibody

Protein level used designations for APOBEC3F

DNA dC->dU-editing enzyme APOBEC-3F , apolipoprotein B mRNA editing enzyme cytidine deaminase , apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3F , induced upon T-cell activation , apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3F , apolipoprotein B mRNA editing enzyme catalytic polypeptide-like 3F

GENE ID SPECIES
200316 Homo sapiens
470275 Pan troglodytes
723812 Macaca mulatta
100037691 Ovis aries
100070221 Equus caballus
Selected quality suppliers for anti-APOBEC3F (APOBEC3F) Antibodies
Did you look for something else?